Liver Treatment Market Scope And Analysis

Report Code : TIPMD00002089
Category : Life Sciences

No. of Pages : 150

Buy Now

Liver Disease Treatment Market Analysis Report 2024 to 2031

Buy Now

Liver Disease Treatment Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 4.41 Billion
Market Size by 2031	US$ 6.94 Billion
Global CAGR (2023 - 2031)	5.8%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Diseases Cirrhosis Hepatitis Cancer and Other Diseases By Imaging Modality Magnetic Resonance Imaging Computed Tomography Ultrasound Other Modalities
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	General Electric Koninklijke Philips N V Siemens AG Canon Medical Systems Corporation Hitachi Ltd Elekta AB pub Neusoft Corporation Samsung Healthcare BPL Medical Technologies Cura Healthcare

Liver Disease Treatment Market News and Recent Developments

The liver disease treatment market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the liver disease treatment market are listed below:

The company launched QP-Liver, which improves the diagnosis of diffuse liver diseases through highly accurate quantification of tissue fat and iron from MRI scans. It has been given a CE and UKCA mark for the European Union and United Kingdom respectively, meaning it is cleared to be used in those markets. (Source: Quibim, Company Website, March 2024)
PerkinElmer Inc launched Vega imaging system, that combines hands-free, automated technology with high-throughput capability to accelerate non-invasive research and drug development studies of cancer, liver and kidney disease, cardiology and more. (Source: AXIS IMAGING NEWS, Newsletter, April 2022)
Royal Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new Liver Fat Quantification tools as part of the latest release of its ultrasound systems EPIQ Elite and Affiniti, bringing the cost and accessibility advantages of sonography to the diagnosis of early-stage liver disease. (Source: Royal Philips, Press Release, November 2021)

Liver Disease Treatment Market Report Coverage and Deliverables

The “Liver Disease Treatment Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Liver Treatment market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Liver Treatment market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
liver disease treatment market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the liver disease treatment market
Detailed company profiles